Compound 1405
Identifiers
- Canonical SMILES:
CCCCN(CCCC)C(=O)c1cc(C)n(n1)-c1ccc(OCC(=O)c2ccccc2)cc1C(=O)N1CCc2ccccc2C1
- IUPAC name:
N,N-dibutyl-1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-4-phenacyloxyphenyl]-5-methylpyrazole-3-carboxamide
- InChi:
InChI=1S/C37H42N4O4/c1-4-6-20-39(21-7-5-2)37(44)33-23-27(3)41(38-33)34-18-17-31(45-26-35(42)29-14-9-8-10-15-29)24-32(34)36(43)40-22-19-28-13-11-12-16-30(28)25-40/h8-18,23-24H,4-7,19-22,25-26H2,1-3H3
- InChiKey:
XIOUWKRWZBNVPX-UHFFFAOYSA-N
External links
![]() 44570093 |
![]() CHEMBL509208 |
![]() 24713969 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.70 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 606.32 g/mol | |||
HBA | 8 | |||
HBD | 0 | |||
HBA + HBD | 8 | |||
AlogP | 6.73 | |||
TPSA | 84.74 | |||
RB | 13 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
19027294 | 43 | BCL2 P10415 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 7.70 | |
19027294 | 43 | B2CL1 Q07817 |
|
Biochemical assay | Time-Resolved FRET | pKi (inhibition constant, -log10) | 5.49 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5875 | Apixaban | DB06605 | |
0.4956 | PF-06291874 | DB15065 | |
0.4924 | Meclinertant | DB06455 | |
0.4847 | Alosetron | DB00969 | |
0.4689 | Nemorexant | DB15031 | |
0.4686 | JHU-75528 C-11 | DB14902 | |
0.4674 | Rimonabant | DB06155 | |
0.4571 | Eluxadoline | DB09272 | |
0.4571 | ISO-1 F-18 | DB14900 | |
0.4461 | Rebastinib | DB13005 | |
0.4433 | Lorlatinib | DB12130 | |
0.4432 | Surinabant | DB13070 | |
0.4416 | 1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole | DB04030 | |
0.4319 | 1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester | DB04469 | |
0.4304 | [5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE | DB08423 |